HCPCS Level IIdrugActive
J2468
Inj, palonosetron (posfrea)
BETOS: O1E
Effective: 2025-01-01
Description
Injection, palonosetron hydrochloride (posfrea), 25 micrograms
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Posfrea
Manufacturer
Avyxa Pharma, LLC
HCPCS Dosage
25 MCG
Billing Units
10.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.